Table 1.
Demographic and clinical characteristics of the 44 patients treated with Enterprise stents for complex symptomatic intracranial stenosis
| N (%) | |
|---|---|
| Age, years | 60.45 ± 9.07 |
| Male gender | 32 (72.73) |
| Symptoms | |
| TIA and other ischemic events | 18 (40.91) |
| Stroke | 26 (59.09) |
| Hypertension | 30 (68.18) |
| Hyperlipidemia | 9 (20.45) |
| Smoking | 11 (25.00) |
| Diabetes mellitus | 13 (29.55) |
| Coronary artery disease | 2 (4.55) |
| Body mass index | |
| 18.5–23.9 | 16 (36.36) |
| 24 ~ 27.9 | 24 (54.55) |
| ≥28 | 4 (9.09) |
| NIHSS score before intervention | |
| 1 | 14 (31.82) |
| 2 | 19(43.18) |
| 3 | 11 (25.00) |
| Time intervals from last event to intervention, day | |
| <30 | 11 (25.00) |
| ≥30 | 33 (75.00) |
| Symptom pattern unstable/stable | 1/43 |
Note: TIA transient ischemic attack, Symptom pattern unstable indicates resolved, improving or unchanging symptoms before the stent placement procedure; unstable indicates progressive or fluctuating neurologic symptoms (National Institutes of Health Stroke Scale score > 4) corresponding to intracranial stenosis within the 2 days prior to the stent placement procedure